Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norketotifen in Acute Uncomplicated Influenza-like Illness
NCT04610047Phase 2Completed
- Sponsor
- Emergo Therapeutics
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of norketotifen in influenza-like illness (ILI), sponsored by Emergo Therapeutics. Started Dec 2020; status: completed.
02
Drugs
norketotifen
03
Conditions
influenza-like illness (ILI)
Beyond the preview
Go deeper on NCT04610047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04610047.